Copyright
©The Author(s) 2024.
World J Gastrointest Surg. Sep 27, 2024; 16(9): 2769-2773
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2769
Published online Sep 27, 2024. doi: 10.4240/wjgs.v16.i9.2769
Genes | Full name | The role in tumor |
PKM2 | Pyruvate kinase M2 | Oncogene |
PRR11 | Proline rich 11 | Oncogene |
TCF7 | Transcription factor 7 | Oncogene |
HMGB1 | High mobility group box 1 | Oncogene |
HDGF | Hepatoma-derived growth factor | Oncogene |
PRDX1 | Peroxiredoxin 1 | Oncogene |
DKK1 | Dickkopf WNT signaling pathway inhibitor 1 | Oncogene |
ADAM17 | A disintegrin and metalloproteinase 17 | Oncogene |
Il-8 | Interleukin 8 | Oncogene |
CUL4A | Cullin 4A | Oncogene |
MTSS1 | Metastasis associated lung adenocarcinoma transcript 1 | Tumor suppressor gene |
RECK | Reversion-inducing-cysteine-rich protein with kazal motifs | Tumor suppressor gene |
SPARCL1 | Secreted protein acidic and rich in cysteine-like 1 | Tumor suppressor gene |
MALAT1 | Metastasis associated lung adenocarcinoma transcript 1 | Tumor suppressor gene |
- Citation: Tang HN, Wang MW, Liu XS, Jiao Y. Personalized treatment of perihilar cholangiocarcinoma based on tumor genetic and molecular characteristics. World J Gastrointest Surg 2024; 16(9): 2769-2773
- URL: https://www.wjgnet.com/1948-9366/full/v16/i9/2769.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v16.i9.2769